Hosted on MSN

Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results , with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was ...
Nasdaq

The Analyst Verdict: Omnicell In The Eyes Of 6 Experts

Ratings for Omnicell (NASDAQ:OMCL) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their ...
Business Wire

Omnicell Announces OmniSphere

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced OmniSphere, a ...
Morningstar

Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on Thursday, ...
Morningstar

Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before market open on Thursday, ...